Our Quality Management System now meets the highest international standard for medical device quality — a critical milestone on our path to CE MDR and scaled clinical deployment of VIOSync.
We did it. Aisthesis Medical is officially ISO 13485:2016 certified — and we couldn’t be more proud of what this represents for our team, our technology, and most importantly, the patients and clinicians we serve.
This is more than a certificate. It’s our ironclad commitment to the trust we must earn at the bedside.
What Is ISO 13485:2016?
ISO 13485 is the internationally recognised standard for Quality Management Systems (QMS) in the design, development, and manufacture of medical devices. Unlike general quality standards, it’s built specifically for the high-stakes demands of healthcare — where errors in processes or software can have real consequences for real patients.
The ISO 13485:2016 revision is the current iteration, aligned with modern regulatory expectations for Software as a Medical Device (SaMD) — precisely the category VIOSync® sits in. Achieving it means our entire quality infrastructure — from how we design features to how we handle complaints and post-market data — has been independently audited and found to meet that standard.
Put simply: this is the quality benchmark that regulators, hospital procurement committees, and healthcare investors look for when evaluating whether a medical device company is serious.
What It Formalises for VIOSync
Our QMS certification formalises three foundational pillars of how VIOSync is built and maintained:
- Patient Safety: Proactive risk management processes and post-market vigilance systems ensure that potential risks are identified, assessed, and mitigated — continuously, not just at launch.
- Clinical-Grade Software (SaMD): Full traceability for how our software is designed, tested, built, and maintained. Every change, every decision, every update — documented and accountable.
- Proven Efficacy Framework: A solid, auditable foundation for our clinical evaluations — ensuring that the evidence base supporting VIOSync is built on rigorous, reproducible processes.
Why This Is Critical for CE MDR and Scale
ISO 13485 isn’t just a standalone badge — it’s a structural prerequisite for CE MDR (EU Medical Device Regulation) compliance, which governs the legal pathway for clinical AI to be deployed across European hospitals.
Without a certified QMS, CE MDR is simply out of reach. With it, we have the quality infrastructure in place to pursue the regulatory approvals that unlock hospital-wide, multi-site, and cross-border deployments of VIOSync — at the scale where it can have the greatest impact on patient outcomes.
This milestone moves us meaningfully closer to that goal. It’s not the finish line — but it’s a major checkpoint that many clinical AI companies never reach.
What This Means If You’re Evaluating Clinical AI
For hospital procurement leads, NHS digital teams, and healthcare investors evaluating clinical AI vendors, ISO 13485 is a key signal. It tells you that:
- The company’s quality processes have been independently audited — not just self-assessed.
- There is a documented, traceable process behind every feature, update, and clinical claim.
- The organisation is building toward regulatory approval — not perpetually piloting in ambiguity.
- Post-market safety is treated as an ongoing obligation, not an afterthought.
In a space where hype frequently outpaces evidence, this kind of institutional rigour matters. We’re building VIOSync to be trusted — and trust has to be earned through process, not just performance.
A Huge Thank You
Achieving ISO 13485 doesn’t happen overnight, and it doesn’t happen alone. A sincere thank you to our team, advisors, auditors, and partners who helped us raise the bar. We’re ready for the next step.
About Aisthesis Medical
Aisthesis Medical is a deep-tech medtech startup developing cutting-edge AI-driven solutions to revolutionize acute care. Founded in 2022, our mission is to save lives by predicting and preventing sepsis before it becomes fatal. Aisthesis Medical is revolutionizing acute care with VIOSync, the first holistic AI-driven sepsis care platform that goes beyond early prediction to guide clinical intervention and optimize patient outcomes. VIOSync, predicts sepsis up to 48 hours earlier, integrates directly into hospital workflows, and optimizes treatment pathways to reduce unnecessary antibiotic use.
Ready to Learn More?
Whether you’re a hospital system, NHS trust, investor, or potential clinical partner — we’d love to connect and share what’s next for VIOSync.
📩 Get in touch: https://aisthesismed.com/contact/
🌐 Learn more about VIOSync: https://aisthesismed.com/product/
📅 Meet us at Tech Tour AI for Health 2026, Bochum — 12–13 March: https://techtour.com/aiforhealth26/